06Jun

One of the nation’s premier biotech centers is finding it so hard to fill jobs the state’s trade association has launched an ambitious marketing campaign to lure workers to Washington state.

“Our industry has jobs. We have jobs at all levels,” said Leslie Alexandre, CEO of the trade group Life Science Washington. “We eagerly welcome people to come and join our ecosystem or to be trained from our schools and colleges.”

The organization hopes to entice workers with a flashy campaign designed to sell the Seattle lifestyle and promote the industry. Life Science Jobs in Washington State, launched last week, with the tag line: “Do your best work. Live your best life.”

In photos, videos and text, the site showcases the Seattle area’s environment and its life sciences industry. The videos have biotech workers telling their stories, extolling the significance of the work they do and the livability of the state. The idea is to introduce the rest of the country to what the state and especially the Puget Sound area has to offer.

Outside the Northwest, said Alexandre, people “simply do not know what Washington is about it.”

The site’s FAQ reinforces the sell. Discussing the cost of living, the site says it’s lower than in “many other life science clusters.,” Industry pay is competitive. The site pitches strongly to families, declaring, “high-ranked schools, abundant parks and excellent healthcare make it one of the best states in the country to raise happy, healthy children.”

Among the initial 217 jobs, the majority are at a senior level, requiring an advanced degree and several years of experience in life sciences. There are, however, several jobs for IT professionals and others, including some mid-level opportunities.

Meg O’Conor Bannecker, public affairs consultant working with Life Science Washington, told the Puget Sound Business Journal the area has a “a growing need for these middle-skill workers.”

She said entry-level jobs in biomanufacturing pay about $42,000, rising to as much as double after only a few years.    

Photo by National Cancer Institute on Unsplash

[bdp_post_carousel]

Jun 6, 2023

What’s the Difference Between the COVID Vaccines?

With the approval last month of the Moderna vaccine by the Food and Drug Administration, we now have two COVID-19 vaccines available. Two more – one from Johnson & Johnson the other from AstraZeneca – are on the way and could be approved as soon as February.

Healthcare workers, residents of nursing facilities and some first responders have already received the Pfizer vaccine, the first one approved by the FDA. Moderna has begun shipping its vaccine with the first of the 25 million initial doses administered last month.

People eager to be immunized have inundated doctors’ offices and clinics asking when the vaccine will be available. The best answer is soon.

Which one, though, will you receive? And does it make any difference?

The answer to the first question is whichever vaccine can be obtained the quickest or, in some cases, whichever your health plan recommends. It really doesn’t make any difference to you.

Both vaccines require two separate doses to reach maximum effectiveness 21 days apart for Pfizer and 28 days for the Moderna version. Both protect about equally well. The FDA data shows Pfizer is 95% effective after both doses. Moderna is 94.1%.

Unlike most other vaccines, these two vaccines use pieces of protein from the SARS-CoV-2 virus to prompt the body to create antibodies. Conventional vaccines, like the annual flu shot, are manufactured from viruses typically grown in chicken eggs. These chicken grown viruses are then killed or weakened to become vaccines.

The COVID vaccines employ messenger RNA (mRNA), a newer technology. These vaccines “teach” the body to replicate the little bit of the CoV-2 protein, which, in turn, creates an immune response causing the body to make the antibodies that provide the protection against the virus.

The most significant difference between the Moderna and the Pfizer vaccines is how they must be stored. Both can survive for a few days in standard refrigeration. For longer periods, the less stable Pfizer vaccine must be kept in ultra-low temperatures below -94 F. That makes shipping and storing Pfizer’s vaccine somewhat more complicated, especially outside urban areas where the low temperature refrigeration is not easily available.

“At the end of the day, these two vaccines are pretty similar,” Dr. Thomas Russo, professor and chief of infectious disease at the State University of New York, tells Health. “Grab it while you can.”

Photo by Hakan Nural

[bdp_post_carousel]